The nitric oxide pathway participates in estrous behavior induced by progesterone and some of its ring A-reduced metabolites

Hormones and Behavior

Volumn 45, Issue 1, 2004, Pages 50-57

  González Flores, Oscar ^a,b   Etgen, Anne M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

cGMP; Guanylyl cyclase; KT5823; L NAME; Lordosis; Nitric oxide; ODQ; Progesterone; Protein kinase G; Ring A reduced progestins

Indexed keywords

5ALPHA PREGNANE 3,20 DIONE; 5ALPHA,3ALPHA PREGNANOLONE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; ELTANOLONE; GESTAGEN; GUANYLATE CYCLASE INHIBITOR; KT 5823; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROGESTERONE; PROGESTERONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; ESTRUS; FEMALE; LORDOSIS; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT; SEXUAL BEHAVIOR;

EID: 0346460267     PISSN: 0018506X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2003.08.003     Document Type: Article

References (64)

1. Agmo A., Soria P., Paredes R. GABAergic drugs and lordosis behavior in the female rat. Horm. Behav. 23:1989;368-389.
2. Beato M., Sánchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr. Rev. 17:1996;587-609.
3. Beyer C., Canchola E. Facilitation of progesterone induced lordosis behavior by phosphodiesterase inhibitors in estrogen primed rats. Physiol. Behav. 27:1981;731-733.
4. Beyer C., González-Mariscal G. Elevation in hypothalamic cyclic AMP as a common factor in the facilitation of lordosis in rodents: a working hypothesis. Ann. N. Y. Acad. Sci. 474:1986;270-281.
5. Beyer C., González-Mariscal G., Eguibar J.R., Gómora P. Lordosis facilitation in estrogen primed rats by intrabrain injection of pregnanes. Pharmacol., Biochem. Beh. 31:1989;919-926.
6. Beyer C., González-Flores O., González-Mariscal G. Ring A reduced progestins potently stimulate estrous behavior in rats: paradoxical effect through the progesterone receptor. Physiol. Behav. 58:1995;985-993.
7. Bjornstrom L., Sjoberg M. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol. Endocrinol. 16:2002;2202-2214.
8. Brann D.W., Bhat G.K., Lamar C.A., Mahesh V.B. Gaseous transmitters and neuroendocrine regulation. Neuroendocrinology. 65:1997;385-395.
9. Ceccatelli S., Grandison L., Scott R.E., Pfaff D.W., Kow L.M. Estradiol regulation of nitric oxide synthase mRNAs in rat hypothalamus. Neuroendocrinology. 64:1996;357-363.
10. Chauchereau A., Cohen-Solal K., Jolivet A., Bailly A., Milgrom E. Phosphorylation sites in ligand-induced and ligand-independent activation of the progesterone receptor. Biochemistry. 33:1994;13295-13303.
11. Cheng Y.J., Karavolas H.J. Conversion of progesterone to 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one by rat medial basal hypothalami and the effects of estradiol and stage of estrous cycle on the conversion. Endocrinology. 93:1973;1157-1162.
12. Chu H.P., Etgen A.M. A potential role of cyclic GMP in the regulation of lordosis behavior of female rats. Horm. Behav. 32:1997;125-132.
13. 1-adrenoceptor activation of the nitric oxide-cGMP pathway: relevance for hormonal facilitation of lordosis behavior. J. Neurosci. 19:1999;7191-7197.
14. Chu H.P., Morales J.C., Etgen A.M. Cyclic GMP may potentiate lordosis behaviour by progesterone receptor activation. J. Neuroendocrinol. 11:1999;107-113.
15. Collado M.I., Rodríguez-Manzo G., Cruz M.L. Effect of progesterone upon adenylate cyclase activity and cAMP levels in brain areas. Pharmacol., Biochem. Behav. 23:1985;501-504.
16. Delville Y. Progesterone-facilitated sexual receptivity: a review of arguments supporting a nongenomic mechanism. Neurosci. Biobehav. Rev. 15:1991;407-414.
17. Dhandapani K.M., Brann D.W. The role of glutamate and nitric oxide in the reproductive neuroendocrine system. Biochem. Cell Biol. 78:2000;165-179.
18. Endo S., Suzuki M., Sumi M., Nairn A.C., Morita R., Yamakawa K., Greengard P., Ito M. Molecular identification of human G-substrate, a possible downstream component of the cGMP-dependent protein kinase cascade in cerebellar Purkinje cells. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2467-2472.
19. Etgen A.M. Progestin receptors and the activation of female reproductive behavior: a critical review. Horm. Behav. 18:1984;411-430.
20. Fernández-Guasti A., Rodríguez-Manzo G., Beyer C. Effect of guanine derivatives on lordosis behavior in estrogen primed rats. Physiol. Behav. 31:1983;589-592.
21. Frye C.A. The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res. Brain Res. Rev. 37:2001;201-222.
22. Frye C.A., DeBold J.F. 3α-OH-DHP and 5α-THDOC implants to the ventral tegmental area facilitate sexual receptivity in hamsters after progesterone priming to the ventral medial hypothalamus. Brain Res. 612:1993;130-137.
23. Frye C.A., Mermelstein P.G., DeBold J.F. Bicuculline infused into the hamster ventral tegmentum inhibits, while sodium valproate facilitates, sexual receptivity. Pharmacol., Biochem. Behav. 46:1993;1-8.
24. Frye C.A., Bayon L.E., Pursnani N.K., Purdy R.H. The neurosteroids, progesterone and 3alpha, 5alpha-THP, enhance sexual motivation, receptivity and proceptivity in female rats. Brain Res. 808:1998;72-83.
25. González-Flores, O., Etgen, A.M., 2002. A role of protein kinases in estrous behavior induced by several progestins. Abstract 482.17, Soc. Neurosci. Annual Meeting.
26. González-Mariscal G., González-Flores O., Beyer C. Intrahypothalamic injection of RU486 antagonizes the lordosis induced by ring A-reduced progestins. Physiol. Behav. 46:1989;435-438.
27. Gorzalka B.B., Whalen R.E. The effects of progestins, mineralocorticoids, glucocorticoids and steroid solubility on the induction of sexual receptivity in rats. Horm. Behav. 8:1977;94-99.
28. Hardy D.F., DeBold J.F. Effects of coital stimulation upon behavior of the female rat. J. Comp. Physiol. Psychol. 78:1972;400-408.
29. Harrison N.L., Simmonds M.A. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res. 323:1984;287-292.
30. Hemmings H.C. Jr., Greengard P. DARPP-32, a dopamine-regulated phosphoprotein. Prog. Brain Res. 69:1986;149-159.
31. Hemmings H.C. Jr., Greengard P., Tung H.Y., Cohen P. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature. 310:1984;503-505.
32. Kimura F., Kawakami M., Nakano H., McCann S.M. Changes in adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate concentrations in the anterior pituitary and hypothalamus during the rat estrous cycle and effects of administration of sodium pentobarbital in proestrus. Endocrinology. 106:1980;631-635.
33. A receptor. Baulieu E.E., Robel P., Schumacher M. Neurosteroids. 1999;167-190 Humana Press, Totowa, NJ.
34. Lange C.A., Richer T., Shen T., Horwitz K.B. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathway. J. Biol. Chem. 273:1998;31303-31316.
35. Lange C.A., Shen T., Horwitz K.B. Phosphorylation of human progesterone receptor at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc. Natl. Acad. Sci. U. S. A. 97:2000;1032-1037.
36. Lo F., Kaufman S. Effect of 5-α-pregnan-3-20-one on nitric oxide biosynthesis and plasma volume in rats. Am. J. Physiol. 280:2001;R1902-R1905.
37. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
38. Mani S.K., Allen J.M., Rettori V., McCann S.M., O'Malley B.W., Clark J.H. Nitric oxide mediates sexual behavior in female rats. Proc. Natl. Acad. Sci. U. S. A. 91:1994;6468-6472.
39. Mani S.K., Fienberg A.A., O'Callaghan J.P., Snyder G.L., Allen P.B., Dash P.K., Moore A.N., Mitchell A.J., Bibb J., Greengard P., O'Malley B.W. Requirement for DARPP32 in progesterone facilitated sexual receptivity in female rats and mice. Science. 287:2000;1053-1056.
40. McCarthy M.M., Malik K.F., Feder H.H. Increased GABAergic transmission in medial hypothalamus facilitates lordosis but has the opposite effect in preoptic area. Brain Res. 507:1990;40-44.
41. A receptors by 5α-pregnan-3α-ol-20-one in the rat brain regions. Brain Res. 832:1999;164-167.
42. Mellon S.H., Vaudry H. Biosynthesis of neurosteroids and regulation of their synthesis. Int. Rev. Neurobiol. 46:2001;33-78.
43. Mellon S.H., Griffin L.D., Compagnone N.A. Biosynthesis and action of neurosteroids. Brain Res. Brain Res. Rev. 37:2001;3-12.
44. Moss R.L., McCann S.M. Induction of mating behavior in rats by luteinizing hormone-releasing hormone. Science. 181:1973;177-179.
45. Negro-Vilar A., Conte D., Valenca M. Transmembrane signals mediating neural peptide secretion: role of protein kinase C activators and arachidonic acid metabolites in luteinizing hormone-releasing hormone secretion. Endocrinology. 119:1986;2796-2802.
46. Ojeda S.R., Urbanski H.F., Katz K.H., Costa M., Conn P.M. Activation of two different but complementary biochemical pathways stimulates release of hypothalamic luteinizing hormone-releasing hormone. Proc. Natl. Acad. Sci. U. S. A. 83:1986;4932-4936.
47. Park-Chung M., Wu F.S., Farb D.H. 3α-Hydroxy-5β-pregnan-20- one sulfate: a negative modulator of the NMDA-induced current in cultured neurons. Mol. Pharmacol. 46:1994;146-150.
48. Pellegrino L.J., Pellegrino A.S., Cushman A. A Stereotaxic Atlas of the Rat Brain. 1979;Plenum, New York.
49. Poletti A., Celotti F., Maggi A., Melcangi R.C., Martini L., Negri-Cesi P. Aspects of hormonal steroid metabolism in the nervous system. Baulieu E.E., Robel P., Schumacher M. Neurosteroids. 1999;97-124 Humana Press, Totowa, NJ.
50. Prince R.J., Simmonds M.A. Steroid modulation of the strychnine- sensitive glycine receptor. Neuropharmacology. 31:1992;201-205.
51. Pu S., Horvath T.L., Diano S., Naftolin F., Kalra P.S., Kalra S.P. Evidence showing that β-endorphin regulates cyclic guanosine 3′,5′ monophosphate (cGMP) efflux: anatomical and functional support for an interaction between opiates and nitric oxide. Endocrinology. 138:1997;1537-1543.
52. Pu S., Kalra P.S., Kalra S.P. Ovarian steroid-independent diurnal rhythm in cyclic GMP/nitric oxide efflux in the medial preoptic area: possible role in preovulatory and ovarian steroid-induced LH surge. J. Neuroendocrinology. 10:1998;617-625.
53. Rachman I.M., Pfaff D.W., Cohen R.S. NADPH diaphorase activity and nitric oxide synthase immunoreactivity in lordosis-relevant neurons of the ventromedial hypothalamus. Brain Res. 740:1996;291-306.
54. Raynaud J.R., Ojasoo T., Pottier J., Salmon J. Chemical substitution of steroid hormones: effect on receptor binding and pharmacokinetics. Litwack G. Biochemical Action of Hormones. 1982;305-342 Academic Press, New York.
55. Reddy D.S., Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effect of neurosteroids on aging- and dizocilpine-induced learning impairment. Brain Res. 799:1998;215-229.
56. Rettori V., Gimeno M., Lyson K., McCann S.M. Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus. Proc. Natl. Acad. Sci. U. S. A. 89:1992;11543-11546.
57. Rupprecht R., Berning B., Hauser C.A., Holsboer F., Reul J.M. Steroid receptor-mediated effects of neuroactive steroids: characterization of structure-activity relationship. Eur. J. Pharmacol. 303:1996;227-234.
58. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 407:2000;538-541.
59. Smith H.E., Smith R.G., Toft D.O., Neegard J.R., Burrows E.P., O'Malley B.W. Binding of steroids to progesterone receptor proteins in chick oviduct and human uterus. J. Biol. Chem. 249:1974;5924-5932.
60. Verma U., Laumas K.R. Screening of anti-progestins using in vitro human uterine progesterone receptor assay system. J. Steroid Biochem. 14:1981;733-740.
61. Whalen R.E., Yahr P., Luttge W.G. The role of metabolism in hormonal control of sexual behavior. Adler N., Pfaff D.W., Goy R.W. Handbook of Behavioral Neurobiology. 1985;609-663 Plenum, New York.
62. Zhang Y., Beck C.A., Poletti A., Edwards D.P., Weigel N.L. Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. Mol. Endocrinol. 9:1995;1029-1040.
63. Zhang Y., Beck C.A., Poletti A., Clement J.P. IV, Prendergast P., Yip T.T., Hutchens T.W., Edwards D.P., Weigel N.L. Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Mol. Endocrinol. 11:1997;823-832.
64. Zubin P., Taleisnik S. Hypothalamic cyclic AMP throughout the four-day estrous cycle of the female rat. Brain Res. 271:1983;273-277.